University of South Australia   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Adelaide Australia (1856)

Organization Overview

First Clinical Trial
2011
NCT01317992
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

University of South Australia

Active Ingredients

Drugs in Phase 4 Trials (4)

methotrexate (1 trial)

ropivacaine (naropin) (1 trial)

sodium chloride (1 trial)

sulfasalazine (azulfidine) (1 trial)

Drugs in Phase 2 Trials (1)

ibudilast (1 trial)

Drugs in Phase 1 Trials (1)

nicotine (nicorette) (1 trial)

Drugs in Other Trials (1)

oryza sativa (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Behavior, Addictive (Phase 1)

Headache (Phase 2)

Headache Disorders, Secondary (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7